Результаты поиска - William E. Hobbs

  • Отображение 1 - 7 результаты of 7
Отмена результатов
  1. 1
    Perturbation of Cell Cycle Progression and Cellular Gene Expression as a Function of Herpes Simplex Virus ICP0

    Perturbation of Cell Cycle Progression and Cellular Gene Expression as a Function of Herpes Simplex Virus ICP0 по William E. Hobbs, Neal A. DeLuca

    Опубликовано 1999
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection

    Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection по Kasey Michelle Eidson, William E. Hobbs, Brian J. Manning, Paul E. Carlson, Neal A. DeLuca

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma

    The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma по Junmei Chen, William E. Hobbs, Jennie Le, Peter J. Lenting, Philip G. de Groot, José A. López

    Опубликовано 2011
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia

    Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia по Catherine M. Broome, Alexander Röth, David J. Kuter, Marie Scully, Roy E. Smith, Jennifer Wang, Caroline Reuter, William E. Hobbs, Ahmed Daak

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

    SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY по Marianela Barros, Alexander Röth, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, David J. Kuter, William E. Hobbs, Jinpeng Su, Xiaoyu Jiang, J. Mateo Arias, Ilene C. Weitz

    Опубликовано 2020
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease

    Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease по Sriram Krishnamoorthy, Betty S. Pace, Dipti Gupta, Sarah Sturtevant, Yaqin Li, Levi Makala, Julia E. Brittain, Nancy Moore, Benjamin Vieira, Timothy D. Thullen, Ivan J. Stone, Li Huo, William E. Hobbs, David R. Light

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Sutimlimab in Cold Agglutinin Disease

    Sutimlimab in Cold Agglutinin Disease по Alexander Röth, Wilma Barcellini, Shirley D’Sa, Yoshitaka Miyakawa, Catherine M. Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Joachim Fruebis, Xiaoyu Jiang, Stella Lin, Caroline Reuter, Jaime Morales‐Arias, William E. Hobbs, Sigbjørn Berentsen

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: